Hansen, J. W., Westman, M. K., Sjö, L. D., Saft, L.
, Kristensen, L. S., Ørskov, A. D., Treppendahl, M., Andersen, M. K.
& Grønbaek, K. (2016).
Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes.
American Journal of Hematology,
91(12), 1234-1238.
https://doi.org/10.1002/ajh.24554
Munch-Petersen, H. D., Asmar, F., Dimopoulos, K., Areškevičiūtė, A., Brown, P., Girkov, M. S.
, Pedersen, A., Sjö, L. D.
, Heegaard, S., Broholm, H.
, Kristensen, L. S., Ralfkiaer, E.
& Grønbæk, K. (2016).
TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
Acta Neuropathologica Communications,
4, 40.
https://doi.org/10.1186/s40478-016-0307-6
Aslan, D., Garde, C., Nygaard, M. K., Helbo, A. S., Dimopoulos, K., Hansen, J. W.
, Severinsen, M. T., Treppendahl, M. B., Sjø, L. D.
, Grønbæk, K. & Kristensen, L. S. (2016).
Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations.
OncoTarget,
7(9), 9951-63.
https://doi.org/10.18632/oncotarget.7127
Helbo, A. S., Treppendahl, M., Aslan, D., Dimopoulos, K., Nandrup-Bus, C.
, Holm, M. S., Andersen, M. K., Liang, G.
, Kristensen, L. S. & Grønbæk, K. (2015).
Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients.
Genes,
6(4), 977-90.
https://doi.org/10.3390/genes6040977
Søes, S., Daugaard, I. L., Sørensen, B. S., Carus, A., Mattheisen, M., Alsner, J., Overgaard, J., Hager, H., Hansen, L. L. & Kristensen, L. S. (2014).
Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation.
Oncoscience,
1(5), 367-74.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278312/
Lade-Keller, J., Kristensen, L. S., Riber-Hansen, R., Guldberg, P., Hansen, L. L., Steiniche, T. & Hager, H. (2013).
A role for immunohistochemical detection of BRAF V600E prior to BRAF-inhibitor treatment of malignant melanoma? Journal of Clinical Pathology,
66(8), 723-5.
https://doi.org/10.1136/jclinpath-2013-201483
Kristensen, L. S., Hansen, L. L., Lade-Keller, J., Riber-Hansen, R., Steiniche, T., Hager, H. & Guldberg, P. (2013).
Author's reply.
The Journal of molecular diagnostics : JMD,
15(4), 536-7.
Lade-Keller, J., Rømer, K. M., Guldberg, P.
, Riber-Hansen, R., Hansen, L. L., Steiniche, T., Hager, H. & Kristensen, L. S. (2013).
Evaluation of BRAF mutation testing methodologies in formalin-fixed, paraffin-embedded cutaneous melanomas.
The Journal of molecular diagnostics : JMD,
15(1), 70-80.
https://doi.org/10.1016/j.jmoldx.2012.08.003
Søes, S., Sørensen, B. S., Alsner, J., Overgaard, J., Hager, H., Hansen, L. L. & Kristensen, L. S. (2013).
Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary Non-Small Cell Lung Cancers and brain and lymph node metastases. Lung Cancer,
81(2), 180-186.
https://doi.org/10.1016/j.lungcan.2013.04.007
Kristensen, L. S., Treppendahl, M. B., Asmar, F., Girkov, M. S.
, Nielsen, H. M., Kjeldsen, T. E., Ralfkiaer, E.
, Hansen, L. L. & Grønbæk, K. (2013).
Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing.
Scientific Reports,
3, 2789.
https://doi.org/10.1038/srep02789
Palma, J. F., Shieh, F.
, Kristensen, L. S., Hansen, L. L., Lade-Keller, J., Riber-Hansen, R., Steiniche, T., Hager, H. & Guldberg, P. (2013).
The challenges of comparing a clinically validated test to other methods.
Journal of Molecular Diagnostics,
15(4), 535-537.
Wojdacz, T. K., Møller, T. H., Thestrup, B. B., Kristensen, L. S. & Hansen, L. L. (2010).
Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies. Expert Review of Molecular Diagnostics,
10(5), 575-580.
Kristensen, L. S., Wojdacz, T. K., Thestrup, B. B., Wiuf, C. H., Hager, H. & Hansen, L. L. (2009).
Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM.
B M C Cancer,
9(453), 453.